metoprolol has been researched along with Apnea, Obstructive Sleep in 5 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we investigated the roles of metoprolol in regulation of atrial remodeling induced by chronic OSA." | 7.85 | Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria. ( Dong, X; Li, H; Li, M; Li, Y; Lu, S; Sun, L; Wang, X; Wang, Y; Yan, S; Yu, S; Zhao, J; Zhao, S, 2017) |
| "Metoprolol protects against chronic OSA-induced cardiac apoptosis and fibrosis in left ventricular myocytes of canines, which may provide new potential strategy for drug therapy of OSA." | 7.81 | Metoprolol Inhibits Cardiac Apoptosis and Fibrosis in a Canine Model of Chronic Obstructive Sleep Apnea. ( Ding, X; Li, H; Li, W; Li, Y; Liu, L; Liu, Z; Peng, W; Wang, D; Yan, S; Zhang, S; Zhao, J, 2015) |
| "Background Whether chronic obstructive sleep apnea ( OSA ) could promote epicardial adipose tissue ( EAT ) secretion of profibrotic adipokines, and thereby contribute to atrial fibrosis, and the potential therapeutic effects of metoprolol remain unknown." | 3.91 | Metoprolol Inhibits Profibrotic Remodeling of Epicardial Adipose Tissue in a Canine Model of Chronic Obstructive Sleep Apnea. ( Dai, H; Gong, Y; Han, Y; Li, T; Li, Y; Sheng, L; Sun, L; Xu, J; Yin, S; Yuan, Y; Zhang, Y, 2019) |
| " Here, we investigated the roles of metoprolol in regulation of atrial remodeling induced by chronic OSA." | 3.85 | Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria. ( Dong, X; Li, H; Li, M; Li, Y; Lu, S; Sun, L; Wang, X; Wang, Y; Yan, S; Yu, S; Zhao, J; Zhao, S, 2017) |
| "Metoprolol protects against chronic OSA-induced cardiac apoptosis and fibrosis in left ventricular myocytes of canines, which may provide new potential strategy for drug therapy of OSA." | 3.81 | Metoprolol Inhibits Cardiac Apoptosis and Fibrosis in a Canine Model of Chronic Obstructive Sleep Apnea. ( Ding, X; Li, H; Li, W; Li, Y; Liu, L; Liu, Z; Peng, W; Wang, D; Yan, S; Zhang, S; Zhao, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, L | 1 |
| Zhao, J | 3 |
| Qu, Y | 1 |
| Sun, Q | 1 |
| Li, TT | 1 |
| Yan, ML | 1 |
| Duan, MJ | 1 |
| Li, KX | 1 |
| Wang, YR | 1 |
| Huang, SY | 1 |
| Zhang, S | 2 |
| Li, Y | 5 |
| Ai, J | 1 |
| Sun, L | 2 |
| Yan, S | 2 |
| Wang, X | 1 |
| Zhao, S | 1 |
| Li, H | 2 |
| Wang, Y | 1 |
| Lu, S | 1 |
| Dong, X | 1 |
| Yu, S | 1 |
| Li, M | 1 |
| Shi, J | 1 |
| Yuan, Y | 2 |
| Deng, X | 1 |
| Pan, Y | 1 |
| He, M | 1 |
| Liu, G | 1 |
| Sun, D | 1 |
| Wang, J | 1 |
| Wang, W | 1 |
| Dai, H | 1 |
| Yin, S | 1 |
| Zhang, Y | 1 |
| Han, Y | 1 |
| Li, T | 1 |
| Xu, J | 1 |
| Sheng, L | 1 |
| Gong, Y | 1 |
| Li, W | 1 |
| Ding, X | 1 |
| Wang, D | 2 |
| Liu, L | 1 |
| Peng, W | 1 |
| Liu, Z | 1 |
1 trial available for metoprolol and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Metoprolol has a similar therapeutic effect as amlodipine on BP lowering in hypertensive patients with obstructive sleep apnea.
Topics: Administration, Oral; Adult; Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory | 2019 |
4 other studies available for metoprolol and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea.
Topics: Animals; Chronic Disease; Dendrites; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; | 2020 |
Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria.
Topics: Adrenergic beta-1 Receptor Antagonists; AMP-Activated Protein Kinase Kinases; Animals; Atrial Fibril | 2017 |
Metoprolol Inhibits Profibrotic Remodeling of Epicardial Adipose Tissue in a Canine Model of Chronic Obstructive Sleep Apnea.
Topics: Adipokines; Adipose Tissue; Animals; Cardiomyopathies; Chronic Disease; Disease Models, Animal; Dogs | 2019 |
Metoprolol Inhibits Cardiac Apoptosis and Fibrosis in a Canine Model of Chronic Obstructive Sleep Apnea.
Topics: Actins; Animals; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; bcl-Associated De | 2015 |